+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acetylcholine"

From
Spasmodic Dysphonia Treatment Market Report 2024 - Product Thumbnail Image

Spasmodic Dysphonia Treatment Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Neurological Disorder Drugs Market Report 2024 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Cholinergic Drugs Global Market Report 2024 - Product Thumbnail Image

Cholinergic Drugs Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Anticholinergic Drugs Global Market Report 2024 - Product Thumbnail Image

Anticholinergic Drugs Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 193 Pages
  • Global
From
Myasthenia Gravis Treatment Market Report 2025 - Product Thumbnail Image

Myasthenia Gravis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Muscarinic Acetylcholine Receptor Market Report 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Spasmodic-torticollis - Pipeline Insight, 2024 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Myasthenia Gravis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 143 Pages
  • Global
From
Loading Indicator

The Acetylcholine market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Acetylcholine is a neurotransmitter that plays a role in muscle contraction, memory, and learning. It is used to treat conditions such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis. Acetylcholine is available in both oral and injectable forms, and is often used in combination with other drugs. The Acetylcholine market is highly competitive, with many companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, GlaxoSmithKline, and Sanofi. Other companies include Allergan, Teva Pharmaceuticals, and Mylan. Show Less Read more